203 related articles for article (PubMed ID: 33609516)
1. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
Simpson CE; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies MK; Vaidya RD; Brandal S; Pauciulo MW; Austin ED; Ivy DD; Nichols WC; Everett AD
Chest; 2020 Jun; 157(6):1606-1616. PubMed ID: 31987881
[TBL] [Abstract][Full Text] [Related]
3. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
Chen JY; Griffiths M; Yang J; Nies MK; Damico RL; Simpson CE; Vaidya RD; Brandal S; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Pediatr; 2020 Aug; 223():164-169.e1. PubMed ID: 32711743
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
[TBL] [Abstract][Full Text] [Related]
5. Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
Sweatt AJ; Miyagawa K; Rhodes CJ; Taylor S; Del Rosario PA; Hsi A; Haddad F; Spiekerkoetter E; Bental-Roof M; Bland RD; Swietlik EM; Gräf S; Wilkins MR; Morrell NW; Nicolls MR; Rabinovitch M; Zamanian RT
Chest; 2021 Oct; 160(4):1442-1458. PubMed ID: 34181952
[TBL] [Abstract][Full Text] [Related]
6. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis.
Samokhin AO; Hsu S; Yu PB; Waxman AB; Alba GA; Wertheim BM; Hopkins CD; Bowman F; Channick RN; Nikolic I; Faria-Urbina M; Hassoun PM; Leopold JA; Tedford RJ; Ventetuolo CE; Leary PJ; Maron BA
J Heart Lung Transplant; 2020 Apr; 39(4):289-299. PubMed ID: 31952977
[TBL] [Abstract][Full Text] [Related]
7. Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
Griffiths M; Yang J; Nies M; Vaidya D; Brandal S; Williams M; Matsui EC; Grant T; Damico R; Ivy D; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
Pediatr Res; 2020 Dec; 88(6):850-856. PubMed ID: 32927467
[TBL] [Abstract][Full Text] [Related]
8. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
9. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
Takatsuki S; Wagner BD; Ivy DD
Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
[TBL] [Abstract][Full Text] [Related]
11. Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension.
Zheng YG; Yang T; He JG; Chen G; Liu ZH; Xiong CM; Gu Q; Ni XH; Zhao ZH
Clin Cardiol; 2014 Jun; 37(6):365-70. PubMed ID: 25068163
[TBL] [Abstract][Full Text] [Related]
12. Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
Khirfan G; Li M; Wang X; Dweik RA; Heresi GA; Tonelli AR
J Heart Lung Transplant; 2021 Jul; 40(7):614-622. PubMed ID: 33962868
[TBL] [Abstract][Full Text] [Related]
13. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
[TBL] [Abstract][Full Text] [Related]
14. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.
Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF
J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658
[TBL] [Abstract][Full Text] [Related]
15. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
[TBL] [Abstract][Full Text] [Related]
16. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
Minhas J; Moutchia J; Al-Naamani N; Mazurek JA; Holmes JH; Appleby D; Smith KA; Fritz JS; Pugliese SC; Palevsky HI; Kawut SM
Ann Am Thorac Soc; 2024 Jun; 21(6):858-865. PubMed ID: 38241602
[No Abstract] [Full Text] [Related]
17. Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
Prins KW; Kalra R; Rose L; Assad TR; Archer SL; Bajaj NS; Weir EK; Prisco SZ; Pritzker M; Lutsey PL; Brittain EL; Thenappan T
J Am Heart Assoc; 2020 Mar; 9(5):e015221. PubMed ID: 32079477
[TBL] [Abstract][Full Text] [Related]
18. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
[TBL] [Abstract][Full Text] [Related]
19. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Bartunek J; Delrue L; Van Durme F; Muller O; Casselman F; De Wiest B; Croes R; Verstreken S; Goethals M; de Raedt H; Sarma J; Joseph L; Vanderheyden M; Weinberg EO
J Am Coll Cardiol; 2008 Dec; 52(25):2166-74. PubMed ID: 19095135
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
